KIR3DL1 and Miyoshi myopathy: Although the difference between the matched and mismatched subsets was not very large, one can anticipate that in an immunosuppressive tumor microenvironment, where the NK cell receives and integrates a multitude of inhibitory signals, reduction of any extra inhibitory signals by KIR-ligand mismatching could help to potentiate the NK cell response against HLA class I competent MM cells.